Improvement of human islet cryopreservation by a p38 MAPK inhibitor

American Journal of Transplantation

Volumn 7, Issue 5, 2007, Pages 1224-1232

  Omori, K ^a   Valiente, L ^a   Orr, C ^a   Rawson, J ^a   Ferreri, K ^a   Todorov, I ^a   Al Abdullah, I H ^a   Medicherla, S ^b   Potter, A A ^b   Schreiner, G F ^b   Kandeel, F ^a   Mullen, Y ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b SCIOS INC   (United States)

Author keywords

Cryopreservation solution; Human islets; p38 MAPK inhibitor

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; ADENOSINE; ALLOPURINOL; AMIDE; ASCORBIC ACID; C PEPTIDE; CYSTEINE; GLUCOSE; GLUTATHIONE; HEAT SHOCK PROTEIN 27; INSULIN; LACTOBIONIC ACID; MAGNESIUM ION; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NICOTINAMIDE; PHOSPHATE; POTASSIUM ION; PRESERVATION SOLUTION; SD 282; SODIUM ION; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; FREEZE THAWING; HEALTH CARE FACILITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; OSMOLARITY; PANCREAS ISLET BETA CELL; PH; PRIORITY JOURNAL; SCID MOUSE; STANDARD;

EID: 34247393334     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01741.x     Document Type: Article

References (44)

1. Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005 54 : 2060 2069.
2. Shapiro AM, Lakey JR, Paty BW, Senior PA, Bigam DL, Ryan EA. Strategic opportunities in clinical islet transplantation. Transplantation 2005 79 : 1304 1307.
3. Hering BJ. Achieving and maintaining insulin independence in human islet transplant recipients. Transplantation 2005 79 : 1296 1297.
4. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000 343 : 230 238.
5. Froud T, Ricordi C, Baidal DA et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005 5 : 2037 2046.
6. Rajotte RV, Stewart HL, Voss WA, Shnitka TK. Viability studies on frozen-thawed rat islets of Langerhans. Cryobiology 1977 14 : 116 120.
7. Kemp JA, Mullen Y, Weissman H, Heininger D, Brown J, Clark WR. Reversal of diabetes in rats using fetal pancreas stored at -196°C. Transplantation 1978 26 : 260 264.
8. Warnock GL, Kneteman NM, Ryan EA, Rabinovitch A, Rajotte RV. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992 35 : 89 95.
9. Arata T, Okitsu T, Fukazawa T et al. Maintenance of glucose-sensitive insulin secretion of cryopreserved human islets with University of Wisconsin solution and ascorbic acid-2 glucoside. Artif Organs 2004 28 : 529 536.
10. Janjic D, Andereggen E, Deng S et al. Improved insulin secretion of cryopreserved human islets by antioxidant treatment. Pancreas 1996 13 : 166 172.
11. Lakey JR, Rajotte RV, Fedorow CA, Taylor MJ. Islet cryopreservation using intracellular preservation solutions. Cell Transplant 2001 10 : 583 589.
12. Kenmochi T, Miyamoto M, Sasaki H et al. LAP-1 cold preservation solution for isolation of high-quality human pancreatic islets. Pancreas 1998 17 : 367 377.
13. Matsuda T, Omori K, Vuong T et al. Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant 2005 5 : 484 493.
14. Nemeth ZH, Deitch EA, Szabo C, Hasko G. Hyperosmotic stress induces nuclear factor-κB activation and interleukin-8 production in human intestinal epithelial cells. Am J Pathol 2002 161 : 987 996.
15. Loomis WH, Namiki S, Ostrom RS, Insel PA, Junger WG. Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation. J Biol Chem 2003 278 : 4590 4596.
16. Raingeaud J, Gupta S, Rogers JS et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995 270 : 7420 7426.
17. Li Z, Tran TT, Ma JY et al. p38 α mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J Cardiovasc Pharmacol 2004 44 : 486 492.
18. Cowan KJ, Storey KB. Mitogen-activated protein kinases: New signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 2003 206 (Pt 7 1107 1115.
19. Yoshinari D, Takeyoshi I, Kobayashi M et al. Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to university of wisconsin solution on reperfusion injury in liver transplantation. Transplantation 2001 72 : 22 27.
20. Koike N, Takeyoshi I, Ohki S, Tokumine M, Matsumoto K, Morishita Y. Effects of adding P38 mitogen-activated protein-kinase inhibitor to celsior solution in canine heart transplantation from non-heart-beating donors. Transplantation 2004 77 : 286 292.
21. Hashimoto N, Takeyoshi I, Yoshinari D et al. Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to Euro-Collins solution on reperfusion injury in canine lung transplantation1. Transplantation 2002 74 : 320 326.
22. Liu K, Yang Y, Mansbridge J. Comparison of the stress response to cryopreservation in monolayer and three-dimensional human fibroblast cultures: Stress proteins, MAP kinases, and growth factor gene expression. Tissue Eng 2000 6 : 539 554.
23. Greenway SC, Storey KB. Activation of mitogen-activated protein kinases during natural freezing and thawing in the wood frog. Mol Cell Biochem 2000 209 : 29 37.
24. Medicherla S, Ma JY, Mangadu R et al. A selective p38 α mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis. J Pharmacol Exp Ther 2006 318 : 132 141.
25. Miyamoto M, Kenmochi T, Nakagawa Y et al. Establishment of an islet bank and its future perspectives. Transplant Proc 1996 28 : 1121 1123.
26. Arita S, Kasraie A, Une S et al. Improved recovery of cryopreserved canine islets by use of beraprost sodium. Pancreas 1999 19 : 289 296.
27. Smith CV, Imagawa DK, Stock PG et al. Simultaneous islet-liver transplantation: Preliminary results from the UC Islet Transplantation Consortium. Transplant Proc 1998 30 : 295 296.
28. Rajotte RV. Islet cryopreservation protocols. Ann N Y Acad Sci 1999 875 : 200 207.
29. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988 45 : 673 676.
30. Hochachka PW. Defense strategies against hypoxia and hypothermia. Science 1986 231 : 234 241.
31. Hochachka PW. Metabolic arrest. Intensive Care Med 1986 12 : 127 133.
32. Roger F, Martin PY, Rousselot M, Favre H, Feraille E. Cell shrinkage triggers the activation of mitogen-activated protein kinases by hypertonicity in the rat kidney medullary thick ascending limb of the Henle's loop. Requirement of p38 kinase for the regulatory volume increase response. J Biol Chem 1999 274 : 34103 34110.
33. Feranchak AP, Berl T, Capasso J, Wojtaszek PA, Han J, Fitz JG. p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability. J Clin Invest 2001 108 : 1495 1504.
34. Kobayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Morishita Y. The role of mitogen-activated protein kinases and the participation of intestinal congestion in total hepatic ischemia-reperfusion injury. Hepatogastroenterology 2006 53 : 243 248.
35. Kaiser RA, Bueno OF, Lips DJ et al. Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J Biol Chem 2004 279 : 15524 15530.
36. Svensson CI, Marsala M, Westerlund A et al. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem 2003 86 : 1534 1544.
37. Woods EJ, Walsh CM, Sidner RA et al. Enhanced recovery of cryopreserved islets using SIS. Transplant Proc 2004 36 : 1139 1142.
38. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, Landry J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 1997 110 (Pt 3 357 368.
39. Lavoie JN, Hickey E, Weber LA, Landry J. Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J Biol Chem 1993 268 : 24210 24214.
40. Lavoie JN, Lambert H, Hickey E, Weber LA, Landry J. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol Cell Biol 1995 15 : 505 516.
41. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002 45 : 749 763.
42. Menger MD, Yamauchi J, Vollmar B. Revascularization and microcirculation of freely grafted islets of Langerhans. World J Surg 2001 25 : 509 515.
43. Duvivier V, Darquy S, Reach G. Cryopreservation of specific pathogen-free (SPF) pig islet cells: Effect of culture time before cryopreservation and after thawing. Cryobiology 1999 38 : 386 397.
44. Piemonti L, Bertuzzi F, Nano R et al. Effects of cryopreservation on in vitro and in vivo long-term function of human islets. Transplantation 1999 68 : 655 662.